Trial intelligence / Profile preview

Cistanche RunTong Oral Liquid for Functional Constipation (Yang-deficiency subtype)

CTR20230059Phase 2Completed

Sponsor
Jiangsu Kanion Pharmaceutical Co., Ltd.
Start
Jan 2023
Countries
1
01

Overview

A Phase 2 trial of Cistanche RunTong oral liquid in functional constipation (FC), sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Jan 2023; status: completed.

02

Drugs

Cistanche RunTong oral liquid
03

Conditions

functional constipation (FC)

Beyond the preview

Go deeper on CTR20230059.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20230059.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call